NSC |
Compound |
Enrichment |
Correlation |
NSC 666787 |
Pyrido[2,3-d]pyrimidine-2,4-diamine, 6-[[(2,3,4- trichlorophenyl)amino]methyl]-5-methyl-, 1/4 acetate |
0.0112341530780143 |
0.36691797 |
NSC 669146 |
6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- |
0.0112341530780143 |
0.33325924 |
NSC 143241 |
Dibenzo[de,g]quinoline-6-carboxylic acid, 4,5-dihydro- 1,2,9,10-tetramethoxy-, ethyl ester |
0.0130238833303634 |
0.78544775 |
NSC 2039 |
Bioquin |
0.0130238833303634 |
0.41302951 |
NSC 315626 |
Butyric acid, rhodium salt (4:2) |
0.0130238833303634 |
0.18156678 |
NSC 329515 |
Kijanimicin sodium salt |
0.0130238833303634 |
0.24057442 |
NSC 673597 |
Null |
0.0130238833303634 |
0.4373029 |
NSC 676794 |
Olean-12-en-28-oic acid, 3-.beta.-(6-methyl-.beta.-D-glucopyranuronosyloxy)-, [2-O-[3-O-(D-.apio.-.beta.-D-ribofuranosy)- 4-O-(.beta.-D-xylopyranosyl)-6-deoxy- .beta.-D-gulopyranosyl]-.beta.-D-xylopy |
0.0130238833303634 |
0.097241861 |
NSC 677369 |
Null |
0.0130238833303634 |
0.22007162 |
NSC 679516 |
Null |
0.0130238833303634 |
0.30636055 |